BRAINXPLORE

Discover the latest news from Etap-LAB

Contact an expert

Published on the 17 May 2019

Syncrosome at the next NeuroFrance Congress in Marseille

SYNCROSOME your dedicated partner for In Vivo Efficacy Studies has been accepted for a poster presentation at NeuroFrance 2019 (Marseille, France, 22-24 May) which is an International Meeting from Soc…

Science and innovation Events
Published on the 21 January 2019

Syncrosome & the Translational Neuroscience Congress

As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and highly reproducible. Syncrosome is involved in Central …

Events
Published on the 19 November 2018

ETAP-Lab participation at the World Preclinical Congress Europe 2018 in Lisbon

ETAP-Lab will be present at the 3rd Annual World Preclinical Congress Europe in Lisbon on November 27-30th. If you are searching for a reliable partner for in vivo preclinical studies, please contact…

Events
Published on the 19 November 2018

Syncrosome will be pleased to meet you at Frankfurt during the 6th DDIP Congress

The 6ThDrug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Frankfurt (Germany) from 29 to 30thof October. This conf…

Science and innovation Events
Published on the 2 May 2017

ETAP-Lab participation to AFSTAL 2017

This year conferences of AFSTAL will focus on Ethology in Animal Experimentation, that is one of the main concerns of our company.

Events
Published on the 6 April 2017

Meta analysis of mesenchymal stem cells in preclinical Parkinson models

Multiple studies have been performed to evaluate the effects of mesenchymal stem cells (MSCs) in preclinical Parkinson models. We performed a meta-analysis to estimate the treatment effect of unmodif…

Science and innovation
Published on the 14 March 2017

Understanding Dyskinesia in 6 OHDA rats Parkinson preclinical model

The pathophysiological mechanisms leading to Dyskinesia in Parkinson’s preclinical models (PD) after long-term treatment with levodopa remain unclear. This study investigates the neuronal firing chara…

Science and innovation
Published on the 7 February 2017

Mechanism behind memory impairment caused by LPS neuro-inflammation

Alzheimer's disease (AD) is a progressive neuro-psychiatric disorder which is characterized by the formation of senile plaques (SPs), extracellular deposits of amyloid beta-peptides (Aβ) following int…

Science and innovation

Discover our scientific resources and browse posters…

Discover our resources